stock and sales statement
DESCRIPTION
STOCKTRANSCRIPT
SANDEEP/CHANDRABHAN HQ VARANASI
PRODUCTS PRICE
1 ALP PLUS 377 0 0 0 02 CLODEP .25 mg 153 5 0 0 53 CLODEP .5 mg 243 5 0 0 54 ULRAX-D 392 8 0 0 85 RAZOTAS 20 mg 679 0 0 0 06 RAZOTAS DSR 245 0 0 0 0
VALUE IN RS
EXISTING PRODUCTS7 Divalp Er-250 254 199 5 5 2098 Divalp Er-500 237 54 5 5 649 Divalp Er-750 343 0 0 0 0
10 Divalp Er-1000 823 0 0 0 011 Dromis-80 576 409 25 25 45912 Dromis-M 713 18 3 3 2413 DIAS 154 0 0 0 014 Ection 1056 35 5 3 4315 Ection-LS 576 9 0 0 916 Fluzine-5 185 80 3 3 8617 Fluzine-10 363 34 3 3 4018 Flupen Plus 672 60 3 3 6619 Febus Tab 494 43 5 5 5320 Febus -80 Tab 809 2 0 0 221 Gapin-m 610 2 0 0 222 Glynit 2.6 65 1020 50 50 112023 Glynit 6.4 90 665 50 50 76524 Hepacure Tab 720 158 3 3 16425 Hepacure-PN 336 5 0 0 526 Hepacure Sachet 69 0 0 0 027 Hepacure Inj. 147 120 5 5 13028 Itomis-50 617 532 35 35 60229 Itomis-Plus 823 5 0 0 530 Lovogut-25 377 103 3 3 10931 Lovogut-50 514 58 0 0 5832 Levogut-RZ 994 202 8 8 21833 Lexilax 101 550 20 20 59034 Misart-40 617 24 3 3 30
NAME OF MSR
LYS APR-JAN 2012-13
PLAN FEB 2013
PLAN MAR 2013
Total 2012-13
NEW PRODUCTS PERFORMANCE
35 Misart-80 1097 9 1 1 1136 Misart-H 686 55 5 5 6537 Misart-A 686 20 3 3 2638 Nepzil-5 514 111 3 3 11739 Nepzil-10 857 6 0 0 640 PGL-M75 651 57 3 3 6341 PGL-M150 994 0 0 0 042 Picsul Tab 439 134 6 6 14643 Prd-Md 405 7 0 0 744 Prd -Sr 1358 10 0 0 1045 Prd plus 672 21 0 0 2146 Prd Inj 17 0 0 0 047 PANDEX TAB 549 0 0 0 048 Tormis 10 370 37 5 5 4749 Tormis-20 713 13 2 2 1750 ULRAX-CAP 377 266 20 15 30151 ULRAX-D 8 0 0 852 Verzin-8 315 67 3 7053 Verzin-16 631 130 3 13354 Verzin-24 946 125 5 5 13555 Zep-5 267 8 3 3 1456 Zep 10 473 35 2 2 3957 Zep 20 823 0 0 0 0
VALUE IN RS
OTHER PRODUCTSMysucral-O 100ml 54.1714 190 0 0 190Picsul-sys 100ml 32.8457 245 20 20 285Picsul Plus-100ml 33.5314 550 20 20 590Picsul plus-200ml 60.2743 1204 50 50 1304Stulax 100ml 54.1714 130 0 0 130Stulax 200ml 106.286 628 25 25 678VALUE IN RS
TOTAL VALUE IN RS
NIKHIL STATE E.UPNAME OF ASM
NAME OF DSM
TARGET 2013-14
VALUE IN RS
% GROWTH PLANNED
SANDEEP KANOJI HQ KANPUR
PRODUCTS PRICE
1 ALP PLUS 377 2 2 42 CLODEP .25 mg 153 0 2 2 43 CLODEP .5 mg 243 5 2 2 94 ULRAX-D 392 15 15 305 RAZOTAS 20 mg 679 0 0 06 RAZOTAS DSR 245 2 2 4
VALUE IN RS
7 Divalp Er-250 254 71 5 5 818 Divalp Er-500 237 141 5 5 1519 Divalp Er-750 343 40 3 3 46
10 Divalp Er-1000 823 20 0 0 2011 Dromis-80 576 20 3 3 2612 Dromis-M 713 25 5 5 3513 DIAS 154 0 0 014 Ection 1056 44 5 5 5415 Ection-LS 576 81 5 5 9116 Fluzine-5 185 0 0 0 017 Fluzine-10 363 2 0 0 218 Flupen Plus 672 81 10 10 10119 Febus Tab 494 7 0 0 720 Febus -80 Tab 809 3 0 0 321 Gapin-m 610 55 5 5 6522 Glynit 2.6 65 15 0 0 1523 Glynit 6.4 90 35 0 0 3524 Hepacure Tab 720 40 5 5 5025 Hepacure-PN 336 0 0 026 Hepacure Sachet 69 0 0 027 Hepacure Inj. 147 330 50 50 43028 Itomis-50 617 0 0 029 Itomis-Plus 823 24 5 5 3430 Lovogut-25 377 53 5 5 6331 Lovogut-50 514 8 1 1 1032 Levogut-RZ 994 200 15 15 23033 Lexilax 101 2986 300 300 358634 Misart-40 617 31 3 3 3735 Misart-80 1097 2 0 0 236 Misart-H 686 29 5 5 39
NAME OF MSR
LYS APR-JAN 2012-13
PLAN FEB 2013
PLAN MAR 2013
Total 2012-13
TARGET 2013-14
NEW PRODUCTS PERFORMANCE
EXISTING PRODUCTS
37 Misart-A 686 13 0 0 1338 Nepzil-5 514 0 0 039 Nepzil-10 857 0 0 040 PGL-M75 651 2 0 0 241 PGL-M150 994 0 0 042 Picsul Tab 439 0 0 043 Prd-Md 405 0 0 044 Prd -Sr 1358 32 3 3 3845 Prd plus 672 20 2 2 2446 Prd Inj 17 0 0 047 PANDEX TAB 549 0 0 048 Tormis 10 370 0 0 049 Tormis-20 713 0 0 050 ULRAX-CAP 377 156 10 10 17651 ULRAX-D 20 2052 Verzin-8 315 45 3 3 5153 Verzin-16 631 29 3 3 3554 Verzin-24 946 9 1 1 1155 Zep-5 267 13 0 0 1356 Zep 10 473 13 0 1357 Zep 20 823 0 0 0 0
VALUE IN RS
Mysucral-O 100m 54.1714 65 0 0 65Picsul-sys 100ml 32.8457 0 0 0Picsul Plus-100ml 33.5314 50 0 0 50Picsul plus-200ml 60.2743 381 50 50 481Stulax 100ml 54.1714 0 0 0Stulax 200ml 106.286 460.5 50 50 561VALUE IN RS
TOTAL VALUE IN RS
OTHER PRODUCTS
PRASHANT NIKHI STATE
E.UP
NAME OF ASM
NAME OF DSM
VALUE IN RS
% GROWTH PLANNED
AJAY LAHRI HQ JHANSI
PRODUCTS PRICE
1 ALP PLUS 377 0 02 CLODEP .25 mg 153 0 0
3 CLODEP .5 mg 243 2 2
4 ULRAX-D 392 2 25 RAZOTAS 20 mg 679 0 06 RAZOTAS DSR 245 3 3
VALUE IN RS
7 Divalp Er-250 2548 Divalp Er-500 237 3 39 Divalp Er-750 343
10 Divalp Er-1000 82311 Dromis-80 57612 Dromis-M 713 10 1013 DIAS 154 0 014 Ection 1056 2 215 Ection-LS 576 3 316 Fluzine-5 18517 Fluzine-10 36318 Flupen Plus 672 10 1019 Febus Tab 49420 Febus -80 Tab 80921 Gapin-m 610 15 1522 Glynit 2.6 65 150 15023 Glynit 6.4 90 25 2524 Hepacure Tab 720 5 525 Hepacure-PN 336 5 526 Hepacure Sachet 69 0 027 Hepacure Inj. 147 25 2528 Itomis-50 617 0 029 Itomis-Plus 823 0 030 Lovogut-25 377 3 331 Lovogut-50 514 1 132 Levogut-RZ 994 8 833 Lexilax 101 50 5034 Misart-40 617 3 335 Misart-80 1097 1 136 Misart-H 686 10 10
NAME OF MSR
LYS APR-JAN 2012-13
PLAN FEB 2013
PLAN MAR 2013
Total 2012-13
TARGET 2013-14
NEW PRODUCTS PERFORMANCE
EXISTING PRODUCTS
37 Misart-A 686 0 038 Nepzil-5 514 0 039 Nepzil-10 85740 PGL-M75 651 2 241 PGL-M150 99442 Picsul Tab 439 2 243 Prd-Md 40544 Prd -Sr 135845 Prd plus 672 5 546 Prd Inj 1747 PANDEX TAB 549 3 348 Tormis 10 37049 Tormis-20 71350 ULRAX-CAP 377 5 551 ULRAX-D52 Verzin-8 315 2 153 Verzin-16 631 2 254 Verzin-24 946 0 055 Zep-5 267 056 Zep 10 473 057 Zep 20 823 0
VALUE IN RS
Mysucral-O 100m 54.1714 50 50Picsul-sys 100ml 32.8457 70 70Picsul Plus-100ml 33.5314 30 30Picsul plus-200ml 60.2743 20 20Stulax 100ml 54.1714 20 20Stulax 200ml 106.286 0 0VALUE IN RS
TOTAL VALUE IN RS
OTHER PRODUCTS
PRASHANT NIKHIL STATE
E.UP
NAME OF ASM
NAME OF DSM
VALUE IN RS
% GROWTH PLANNED
SUSHEEL PRAJAPAHQ ALLAHABAD
PRODUCTS PRICE
1 ALP PLUS 377 0 1 1 22 CLODEP .25 mg 153 3 5 5 133 CLODEP .5 mg 243 0 2 2 44 ULRAX-D 392 2 2 45 RAZOTAS 20 mg 679 0 0 06 RAZOTAS DSR 245 2 2 4
VALUE IN RS
7 Divalp Er-250 254 181 15 15 2118 Divalp Er-500 237 412 20 20 4529 Divalp Er-750 343 134 10 10 154
10 Divalp Er-1000 823 14 5 5 2411 Dromis-80 576 5 0 0 512 Dromis-M 713 405 30 30 46513 DIAS 154 15 0 0 1514 Ection 1056 30 5 5 4015 Ection-LS 576 225 15 15 25516 Fluzine-5 185 25 10 10 4517 Fluzine-10 363 131 10 10 15118 Flupen Plus 672 115 10 10 13519 Febus Tab 494 15 3 3 2120 Febus -80 Tab 809 4 3 3 1021 Gapin-m 610 146 10 10 16622 Glynit 2.6 65 90 0 0 9023 Glynit 6.4 90 50 0 0 5024 Hepacure Tab 720 49 3 3 5525 Hepacure-PN 336 30 3 3 3626 Hepacure Sachet 69 0 0 0 027 Hepacure Inj. 147 50 0 0 5028 Itomis-50 617 0 0 029 Itomis-Plus 823 0 0 030 Lovogut-25 377 88 5 5 9831 Lovogut-50 514 1 1 232 Levogut-RZ 994 0 0 033 Lexilax 101 350 50 50 45034 Misart-40 617 108 5 5 118
NAME OF MSR
LYS APR-JAN 2012-13
PLAN FEB 2013
PLAN MAR 2013
Total 2012-13
NEW PRODUCTS PERFORMANCE
EXISTING PRODUCTS
35 Misart-80 1097 5 2 2 936 Misart-H 686 167 10 10 18737 Misart-A 686 4 2 2 838 Nepzil-5 514 0 0 039 Nepzil-10 857 0 0 040 PGL-M75 651 11 0 0 1141 PGL-M150 994 0 0 042 Picsul Tab 439 9 1 1 1143 Prd-Md 405 30 2 2 3444 Prd -Sr 1358 5 0 0 545 Prd plus 672 189 5 5 19946 Prd Inj 17 0 0 047 PANDEX TAB 549 26 0 0 2648 Tormis 10 370 30 0 0 3049 Tormis-20 713 10 0 0 1050 ULRAX-CAP 377 17 5 5 2751 ULRAX-D 3 1 1 552 Verzin-8 315 118 5 5 12853 Verzin-16 631 74 5 5 8454 Verzin-24 946 10 1 1 1255 Zep-5 267 34 5 5 4456 Zep 10 473 29 5 5 3957 Zep 20 823 0 0 0 0
VALUE IN RS
Mysucral-O 100m 54.1714 155 0 0 155Picsul-sys 100ml 32.8457 255 20 20 295Picsul Plus-100ml 33.5314 280 25 25 330Picsul plus-200ml 60.2743 68 0 0 68Stulax 100ml 54.1714 60 10 10 80Stulax 200ml 106.286 20 10 10 40VALUE IN RS
TOTAL VALUE IN RS 12.1
OTHER PRODUCTS
PRASHANT M NIKHIL STATE
E.UP
NAME OF ASM
NAME OF DSM
TARGET 2013-14
VALUE IN RS
% GROWTH PLANNED
BRIJESH/DHANJA HQ
PRODUCTS PRICE
1 ALP PLUS 377 3 3 62 CLODEP .25 mg 153 5 5 103 CLODEP .5 mg 243 5 5 104 ULRAX-D 392 10 10 205 RAZOTAS 20 mg 679 0 0 06 RAZOTAS DSR 245 5 3 8
VALUE IN RS
7 Divalp Er-250 254 08 Divalp Er-500 237 148 5 5 1589 Divalp Er-750 343 0
10 Divalp Er-1000 823 38 5 5 4811 Dromis-80 576 109 5 5 11912 Dromis-M 713 0 5 5 1013 DIAS 154 0 0 014 Ection 1056 0 5 5 1015 Ection-LS 576 200 5 5 21016 Fluzine-5 185 5 5 1017 Fluzine-10 363 5 5 1018 Flupen Plus 672 41 5 5 5119 Febus Tab 494 0 0 0 020 Febus -80 Tab 809 0 0 021 Gapin-m 610 30 5 5 4022 Glynit 2.6 65 560 50 50 66023 Glynit 6.4 90 250 25 25 30024 Hepacure Tab 720 162 0 0 16225 Hepacure-PN 336 258 5 5 26826 Hepacure Sachet 69 156 20 20 19627 Hepacure Inj. 147 1452 150 150 175228 Itomis-50 617 80 5 5 9029 Itomis-Plus 823 3 5 5 1330 Lovogut-25 377 108 5 5 11831 Lovogut-50 514 19 3 3 2532 Levogut-RZ 994 1 5 5 1133 Lexilax 101 515 150 150 81534 Misart-40 617 8 8 16
NAME OF MSR
LYS APR-JAN 2012-13
PLAN FEB 2013
PLAN MAR 2013
Total 2012-13
NEW PRODUCTS PERFORMANCE
EXISTING PRODUCTS
35 Misart-80 1097 0 0 036 Misart-H 686 5 5 1037 Misart-A 686 1 0 0 138 Nepzil-5 514 0 0 039 Nepzil-10 857 0 0 040 PGL-M75 651 5 5 1041 PGL-M150 994 0 0 042 Picsul Tab 439 13 5 5 2343 Prd-Md 405 5 5 1044 Prd -Sr 1358 114 5 5 12445 Prd plus 672 255 5 5 26546 Prd Inj 17 0 0 047 PANDEX TAB 549 2 5 5 1248 Tormis 10 370 0 0 049 Tormis-20 713 0 0 050 ULRAX-CAP 377 5 5 1051 ULRAX-D 052 Verzin-8 315 133 5 5 14353 Verzin-16 631 85 5 5 9554 Verzin-24 946 8 3 3 1455 Zep-5 267 0 056 Zep 10 473 0 057 Zep 20 823 0 0
VALUE IN RS
Mysucral-O 100m 54.1714 450 50 50 550Picsul-sys 100ml 32.8457 953 100 100 1153Picsul Plus-100ml 33.5314 238 0 0 238Picsul plus-200ml 60.2743 522 50 50 622Stulax 100ml 54.1714 0 0 0Stulax 200ml 106.286 807.8 50 50 908VALUE IN RS
TOTAL VALUE IN RS
OTHER PRODUCTS
RAJEEV NIKHIL STATE
E.UP
NAME OF ASM
NAME OF DSM
TARGET 2013-14
VALUE IN RS
% GROWTH PLANNED
STOCK AND SALES STATEMENTNAME OF MSR- HQ- MONTH-
PRODUCTS TOTAL
1 ULRAX 37.72 ULRAX-D 19.63 CLODEP .25 mg 10.34 CLODEP .5 mg 16.55 Flupen Plus 33.66 Ection 52.87 Ection-LS 28.88 Levogut-RZ 99.49 Lovogut-25 37.7
10 Lovogut-50 51.411 RAZOTAS 20 mg 30.912 RAZOTAS DSR 41.113 ALP PLUS 18.914 Divalp Er-250 25.415 Divalp Er-500 47.316 Divalp Er-750 68.617 Divalp Er-1000 82.318 Dromis-80 28.819 Dromis-M 35.720 DIAS 30.921 Fluzine-5 9.322 Fluzine-10 18.223 Febus Tab 49.424 Febus -80 Tab 80.925 Gapin-m 61.026 Glynit 2.6 65.127 Glynit 6.4 89.828 Hepacure Tab 72.029 Hepacure-PN 33.630 Hepacure Sachet 68.631 Hepacure Inj. 147.432 Itomis-50 30.933 Itomis-Plus 82.334 Lexilax 101.535 Misart-40 30.936 Misart-80 54.937 Misart-H 34.3
PRICE (Strips)
OPENING STOCK
RECEIVED DURING THE
MONTH
38 Misart-A 34.339 Nepzil-5 51.440 Nepzil-10 85.741 PGL-M75 65.142 PGL-M150 99.443 Picsul Tab 21.944 Prd-Md (5*20) 80.945 Prd -Sr 67.946 Prd plus 33.647 Prd Inj 17.148 PANDEX TAB 27.449 Tormis 10 18.550 Tormis-20 33.751 Verzin-8 15.852 Verzin-16 31.553 Verzin-24 47.354 Zep-5 (5*20) 53.555 Zep 10 (5*20) 94.656 Zep 20 (5*20) 164.657 Mysucral-O 100ml 54.258 Picsul-sys 100ml 32.859 Picsul Plus-100ml 33.560 Picsul plus-200ml 60.361 Stulax 100ml 54.262 Stulax 200ml 106.3
TOTAL VALUE IN RS
STOCK AND SALES STATEMENTMONTH- NAME OF ASM-
SALE VALUE IN RS
0000000000000000000000000000000000000
CLOSING STOCK
LAST MONTH
SALE
0000000000000000000000000
0 0 0
EKHLAQ AHMAD HQ FAIZABAD
PRODUCTS PRICE
1 ALP PLUS 377 0 02 CLODEP .25 mg 153 0 03 CLODEP .5 mg 243 0 04 ULRAX-D 392 0 05 RAZOTAS 20 mg 679 0 1 16 RAZOTAS DSR 245 0 2 2
VALUE IN RS
7 Divalp Er-250 254 4 48 Divalp Er-500 237 9 99 Divalp Er-750 343 10 10
10 Divalp Er-1000 823 0 011 Dromis-80 576 0 012 Dromis-M 713 0 1 113 DIAS 154 0 014 Ection 1056 0 015 Ection-LS 576 18 1 1916 Fluzine-5 185 0 017 Fluzine-10 363 4 418 Flupen Plus 672 10 1019 Febus Tab 494 0 020 Febus -80 Tab 809 0 021 Gapin-m 610 38 3822 Glynit 2.6 65 75 5 8023 Glynit 6.4 90 0 024 Hepacure Tab 720 0 025 Hepacure-PN 336 27 2726 Hepacure Sachet 69 56 5627 Hepacure Inj. 147 300 30028 Itomis-50 617 0 029 Itomis-Plus 823 0 030 Lovogut-25 377 50 1 5131 Lovogut-50 514 0 032 Levogut-RZ 994 0 1 133 Lexilax 101 8 834 Misart-40 617 0 0
NAME OF MSR
LYS APR-JAN 2012-13
PLAN FEB 2013
PLAN MAR 2013
Total 2012-13
NEW PRODUCTS PERFORMANCE
EXISTING PRODUCTS
35 Misart-80 1097 0 036 Misart-H 686 4 437 Misart-A 686 5 538 Nepzil-5 514 0 039 Nepzil-10 857 0 040 PGL-M75 651 17 1741 PGL-M150 994 0 042 Picsul Tab 439 7 1 843 Prd-Md 405 18 1 1944 Prd -Sr 1358 0 1 145 Prd plus 672 18 1 1946 Prd Inj 17 0 047 PANDEX TAB 549 0 2 248 Tormis 10 370 10 1049 Tormis-20 713 0 050 ULRAX-CAP 377 23 2 2551 ULRAX-D 0 1 152 Verzin-8 315 30 2 3253 Verzin-16 631 3 2 554 Verzin-24 946 0 055 Zep-5 267 2 256 Zep 10 473 4 457 Zep 20 823 2 2
VALUE IN RS
Mysucral-O 100m 54.1714 25 20 45Picsul-sys 100ml 32.8457 19 19Picsul Plus-100ml 33.5314 22 22Picsul plus-200ml 60.2743 0 10 10Stulax 100ml 54.1714 30 30Stulax 200ml 106.286 36 10 46VALUE IN RS
TOTAL VALUE IN RS
OTHER PRODUCTS
RAJEEV NIKHIL STATENAME OF ASM
NAME OF DSM
TARGET 2013-14
VALUE IN RS
% GROWTH PLANNED
PRIYANKA/PRAFULL HQ LUCKNOW
PRODUCTS PRICE
1 ALP PLUS 377 0 5 5 102 CLODEP .25 mg 153 2 0 3 5
3 CLODEP .5 mg 243 2 0 3 5
4 ULRAX-D 392 2 5 10 175 RAZOTAS 20 mg 679 1 0 4 56 RAZOTAS DSR 245 2 2 5 9
VALUE IN RS
EXISTING PRODUCTS7 Divalp Er-250 254 2 0 0 28 Divalp Er-500 237 7 0 0 79 Divalp Er-750 343 0 0 0 0
10 Divalp Er-1000 823 0 0 0 011 Dromis-80 576 382 25 25 43212 Dromis-M 713 60 3 3 6613 DIAS 154 0 0 0 014 Ection 1056 85 15 15 11515 Ection-LS 576 64 15 15 9416 Fluzine-5 185 0 2 2 417 Fluzine-10 363 3 3 4 1018 Flupen Plus 672 2 3 3 819 Febus Tab 494 5 4 4 1320 Febus -80 Tab 809 0 0 0 021 Gapin-m 610 0 0 0 022 Glynit 2.6 65 85 10 10 10523 Glynit 6.4 90 20 0 0 2024 Hepacure Tab 720 12 5 5 2225 Hepacure-PN 336 2 2 2 626 Hepacure Sachet 69 0 10 10 2027 Hepacure Inj. 147 0 0 0 028 Itomis-50 617 58 0 0 5829 Itomis-Plus 823 149 0 0 14930 Lovogut-25 377 166 15 20 20131 Lovogut-50 514 0 0 0 032 Levogut-RZ 994 30 0 0 3033 Lexilax 101 105 20 20 14534 Misart-40 617 2 2 0 4
NAME OF MSR
LYS APR-JAN 2012-13
PLAN FEB 2013
PLAN MAR 2013
Total 2012-13
NEW PRODUCTS PERFORMANCE
35 Misart-80 1097 0 0 0 036 Misart-H 686 2 2 0 437 Misart-A 686 0 2 0 238 Nepzil-5 514 0 0 0 039 Nepzil-10 857 0 0 0 040 PGL-M75 651 0 2 2 441 PGL-M150 994 0 0 0 042 Picsul Tab 439 20 3 2 2543 Prd-Md 405 2 0 0 244 Prd -Sr 1358 1 0 0 145 Prd plus 672 2 3 2 746 Prd Inj 17 0 0 0 047 PANDEX TAB 549 0 2 2 448 Tormis 10 370 1 0 0 149 Tormis-20 713 13 0 0 1350 ULRAX-CAP 377 13 10 15 3851 ULRAX-D 2 5 10 1752 Verzin-8 315 6 2 2 1053 Verzin-16 631 5 3 5 1354 Verzin-24 946 1 2 2 555 Zep-5 267 4 0 0 456 Zep 10 473 6 0 0 657 Zep 20 823 0 0 0 0
VALUE IN RS
OTHER PRODUCTSMysucral-O 100ml 54.1714 10 10 10 30Picsul-sys 100ml 32.8457 4414 300 300 5014Picsul Plus-100ml 33.5314 660 20 30 710Picsul plus-200ml 60.2743 1858 200 200 2258Stulax 100ml 54.1714 175 10 10 195Stulax 200ml 106.286 68 10 10 88VALUE IN RS
TOTAL VALUE IN RS 10.4
NIKHIL STATE E.UPNAME OF ASM
NAME OF DSM
TARGET 2013-14
VALUE IN RS
% GROWTH PLANNED
